Candidate genes offer one approach to the identification of the genetic susceptibility to hypertension. A common gene variant of the low-density lipoprotein (LDL) receptor gene (LDLR) that affects plasma LDL metabolism within the normolipidaemic range, may be such a candidate gene. A common mutation of LDLR, C1773T, was associated with lipid metabolism such that the T1773 allele increased plasma LDL levels in a Caucasian population. The present study examined whether C1773T/LDLR was associated with essential hypertension in a Japanese population. Subjects with essential hypertension (EHT, n = 300) with a family history of hypertension, and controls (NT, n = 310, sex-and agematched with EHT) were recruited from among outpatients at Osaka University Hospital. A C1773T substitution at codon 570 in LDLR was determined using PCR-
Introduction
Essential hypertension is considered to be a multifactorial disease involving genetic and environmental factors.
1,2 Both factors may interact, leading to chronically elevated blood pressure. Recent advances in molecular biology have allowed the investigation of candidate genes for hypertension. [3] [4] [5] Considering the biochemical and physiological mechanisms involved in regulating blood pressure, many candidates have been listed as hypertensive genes. Although a large number of potential candi-Hinc II-RFLP. It was revealed that the C1773 allele was significantly more frequent (0.89) among hypertensive patients ( 2 = 9.58, P Ͻ 0.01) than normotensives (0.83), the calculated odds ratio being 1.7 (95% CI: 1.2-2.4). The effect of the T1773 allele on increasing cholesterol was significant in normotensives without antihyperlipidaemic medication, but not in hypertensives. After adjustments of confounding factors, the estimated odds ratio for hypertension in the subjects with C1773 homozygote increased to 2.1 (95% CI: 1.3-3.5), suggesting that this polymorphism is an independent risk factor for hypertension. Our results show that the C1773 mutant of LDLR increases susceptibility to hypertension, but not via hypercholesterolaemia.
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date genes have been investigated with regard to human and rat hypertension, few studies have been conclusive. This may reflect difficulties in the replication of supportive findings under complex circumstances modulating hypertension, such as the heterogeneous nature of genetic susceptibility and gene-environment interactions. 6 The affected sib-pair method has revealed that angiotensinogen, lipoprotein lipase and ␣-adducin gene polymorphisms are genetic risk factors for human essential hypertension, [7] [8] [9] but no specific gene clearly governing susceptibility for hypertension has yet been identified. The low-density lipoprotein (LDL) receptor is one candidate that plays an integral role in plasma lipoprotein metabolism. 10 A recent paper showing the male-associated hypertension in LDLR deficient mice suggested the possibility that LDLR gene was not only involved in lipid metabolism but also in the unknown pathogenesis
Journal of Human Hypertension of hypertension. 11 The human LDL receptor gene (LDLR) consists of 18 exons and 17 introns with the  length of approximately 45 kb, and is mapped to  chromosome 19p13.2. 12 Mutations in the LDLR gene, of which over 150 have been described, 13 underlie familial hypercholesterolaemia (FH). FH heterozygotes have markedly elevated total and LDL cholesterol and frequently develop early coronary heart disease (CHD). However, the heterozygous FH phenotype is relatively rare, with a frequency of about 1 in 500 Caucasians. 14 The importance of common LDLR variations as determinants of plasma LDL metabolism, particularly within the normolipidaemic range, has not been clarified. A recent report by Boright et al 15 revealed that a common mutation of LDLR, C1773T, is associated with lipid metabolism and that the T1773 allele increases plasma LDL levels in the Alberta Hutterites. This unique population with a homogenous environmental and genetic background is a useful tool for genetic study 16 and is similar in that respect to a Japanese population. Boright et al 15 reported that a common variation of LDLR, for which the codon 570 variation is a marker, is both associated and linked with a modest but significant variation in plasma LDL cholesterol in normolipidaemic individuals. 17 Other findings also highlight the importance of both the markers and the analytical strategy with which to identify the genetic determinants of complex diseases. 18 To clarify the role of common gene variants of the LDLR in essential hypertension, we examined the association between C1773T polymorphism of LDLR and hypertension among 610 Japanese.
Patients and methods

Population
Patients with essential hypertension and controls were selected from Japanese out-patients of the Department of Geriatric Medicine, Osaka University Medical School. All participants gave informed consent before participating in the research protocol, which was approved by the Hospital Ethics Committee. The criteria for hypertension were defined as systolic blood pressure у160 mm Hg, diastolic blood pressure у95 mm Hg, or under antihypertensive therapy. Hypertensive subjects were defined with a family history of hypertension (presence of hypertensive relatives within the second degree) and without secondary hypertension (primary aldosteronism, pheochromocytoma, hyperthyroidism, renovascular hypertension, or Cushing's syndrome), diabetes mellitus and ischaemic heart disease, resulting in 300 cases who participated in the case control study. Sex-and age-matched controls were recruited from the outpatients clinic in the same institution, and those with past history of hypertension, diabetes mellitus or ischaemic heart disease were excluded. We also excluded individuals with 
Determination of LDLR genotypes
DNA was extracted from 200 L of buffy coat using QIAamp Kit (QIAGEN Inc, Santa Clarita, CA, USA). The polymerase chain reaction (PCR) was proceeded using 100 ng of genomic DNA as template and Omni Gene (Hybaid) thermal cycler. To amplify the shorter flanking region of the LDLR common variant (C1773T), we designed the primer set as follows: sense, 5Ј-TCT CCT TAT CCA CTT GTG TGT-3Ј; antisense, 5Ј-CTT CGA TCT CGT ACG TAA GC-3Ј. DNA was amplified by an initial denaturation at 94°for 5 min, followed by 35 cycles of 94°for 1 min, 56°for 1 min and 72°for 1 min. PCR products were digested with 1 U of Hinc II (Promega Co, USA) at 37°overnight. 19 All digested products were separated on 3.0% MetaPhor agarose gels (FMC BioProducts) and visualized by ethidium bromide staining.
Statistical analysis
All statistical analyses were conducted using StatView 4.5J (Abacus Concepts, Berkeley, CA, USA) and JMP 3.0 (SAS Inc, Cary, NC, USA). The difference in genotype distribution between patients and controls was examined by the 2 analysis. The association between the common variant of LDLR (C1773T) and clinical variables was examined by one-way analysis of variance. We used JMP for multiple logistic regression analysis to assess the quantitative effects of the covariates (gender, age, body mass index (BMI), fasting plasma glucose (FPG), triglyceride (TG) and antihyperlipidaemic medication).
Results
Distribution of common variation of LDLR (C1773T) in Japanese
BMI, FPG, TG levels and percentage of subjects under antihyperlipidaemic medication were higher in hypertensives than in controls, but all other characteristics were similar between the two groups except blood pressure ( Table 2 shows that C1773 allele was significantly more frequent (89.3%) in hypertensives ( 2 = 9.58, P Ͻ 0.01) than that in normotensives (83.1%), the calculated odds ratio being 1.71 (95% CI: 1.22-2.38). Since it has not been clarified which allele (C or T) has the dominant effect, the genotype-phenotype correlation was examined under the following situations: among three genotypes (CC, CT and TT), between patients with and without the C allele (CC + CT vs TT), and between those with and without the T allele (CC vs CT + TT). The calculated odds Journal of Human Hypertension ratio for hypertension between patients with and without C allele were 3.24 (95% CI: 1.04 -10.0). However, only four hypertensives did not have a C allele and the 95% confident interval was broad, suggesting that the significance was unstable. In contrast, the difference between with and without the T allele was significant with the odds ratio being estimated as 1.69 (95% CI: 1.16-2.45). To exclude false-positive association due to the effect of a rare genotype, we examined the association between with and without the T allele (CC vs CT + TT).
Association with essential hypertension and with lipid metabolism
To verify the correlation between lipids and the common mutation of LDLR, we examined whether the C1773T polymorphism was associated with various lipid levels or with antihyperlipidaemic medication (Tables 3 and 4 ). In normotensives without antihyperlipidaemic medication, the C1773T polymorphism was associated with total and LDL cholesterol levels but not with triglyceride or HDL cholesterol levels. Normotensive subjects with a T1773 allele had 5.9% higher total cholesterol and 9.0% higher LDL cholesterol levels than those lacking that allele (Table 4) . However, the positive association was not observed among hypertensives and subjects under antihyperlidemic medication in the present study. Neither the parameter for glucose metabolism nor obesity was associated with the C1773T polymorphism. 
The effect test of confounding factors for hypertension and for lipid concentration
To define the exact effect of C1773T polymorphism, we performed multiple logistic regression analyses. BMI, triglyceride, FPG and the presence of antihyperlipidaemic medication were used as confounding factors because there were significant differences among basic characteristics between hypertensives and normotensives. Multiple logistic regression analysis revealed that the presence of antihyperlipidaemic medication, BMI, FPG and the absence of T1773 allele (Wald 2 1 = 8.3, P = 0.0039) were significantly associated with hypertension, while sex, age and TG did not. The estimated odds ratio for hypertension in the subjects with C1773 Table 6 Comparison between subgroups in the genetic predisposition to hypertension according to LDLR common polymorphism
Subjects
Statistical significance of association with hypertension homozygote was 2.1 (95% CI: 1.3-3.5) after adjustments of confounding factors.
On the other hand, the effect of T1773 allele was examined with the consideration of confounding factors (antihyperlipidaemic and antihypertensive medication, FPG, BMI, age, and sex). The effect of T1773 allele in the increase of plasma LDL level remained after adjustment for confounding factors (Table 5) .
Furthermore, we compared subgroups (obesity (+) vs (−), hyperlipidaemia (+) vs (−), and hyperglycaemia (+) vs (−)) in the association between genotype and prevalence of hypertension. LDLR C1773 allele increased the genetic predisposition to hypertension in the subjects with hyperlipidaemia and without obesity and hyperglycaemia (Table 6 ).
Discussion
Essential hypertension is a common disease and over 30 million Japanese have hypertension. The development of antihypertensive medication had decreased mortality due to cardiovascular disease but this decrease has bottomed out. 20 To improve the current status, a genetic approach to clarify the pathogenesis of essential hypertension makes a powerful tool. Genetic studies of hypertension have identified several candidate genes using the affected sib-pair method or case-control studies. Incomplete penetrance and late onset of hypertension complicate the use of linkage analysis for screening the entire human genome, suggesting that the candidate gene approach still has an advantage over the affected sib-pair method in terms of statistics. However, a few candidate genes considered to be potentially aetiological for hypertension did exhibit a positive association. We therefore began to examine genes that indirectly may affect blood pressure.
Several publications suggest that most LDLR gene mutations cause familial hyperlipidaemia. 21, 22 In contrast, Boright et al 15 recently emphasised the importance of a common LDLR mutation in affecting the plasma LDL cholesterol level in the normolipidaemic population. In the present study, we postulated that the common LDLR mutation, C1773T, may be involved in the hypertension trait and carried out an association study. Our study revealed that the C1773T polymorphism was associated with plasma total cholesterol and LDL cholesterol levels in normotensive individuals without antihyperlipidaemic medication (Table 4) . However, we found that the frequency of the T1773 allele was much lower in Japanese than in Caucasians, which may be a reason for the low morbidity due to coronary heart disease in Japan.
On the other hand, a significant difference in the C1773T genotype distribution between patients and controls suggests its association with hypertension. This contrasts to our first thesis that the T1773 allele is negatively associated with hypertension; rather, the absence of the T1773 allele appears to increase the risk for hypertension. Currently, we could not deduce a feasible conclusion from the present results. However, the increase in the significance of association with hypertension in the subjects with hyperlipidaemia and without obesity and hyperglycaemia may suggest an unknown function of LDLR.
In summary, this is the first evidence of a direct association between the LDLR gene and hypertension, although other evidence was interpreted such that the LDLR locus on chromosome 19 may be a candidate for obesity in patients with hypertension. 23, 24 The multiple logistic regression analysis revealed that the C1773T polymorphism is an independent predisposing factor for hypertension (Table  5) . Several candidate genes showing the positive association with hypertension (insulin receptor, 25 glycogen synthase, 26 and prostaglandin I 2 receptor
)
Journal of Human Hypertension are also mapped on the same chromosome 19, suggesting another possibility. Namely, the results we report may be due to the effect of an anonymous gene in the linkage disequilibrium with C1773T polymorphism. For example, the insulin receptor was mapped within the same region of chromosome, 19p13.2, raising the possibility that this locus may also play a key role in insulin resistance and hypertension. Our results indicate that the association between LDLR and hypertension should be examined among other ethnic populations which should clarify the putative novel function of LDLR and hypertension.
